-
1
-
2
-
3
-
4
-
5
-
6
-
7
Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance
Published 2019-02-01“…This is a quality improvement project to investigate reasons for nonadherence and medication errors in patients receiving oral investigational treatment at the Phase 1 Department at MD Anderson Cancer Center, Houston, Texas. Early-phase clinical trials have an enormous impact on drug development and patient safety, not much has been done to evaluate adherence in patients receiving investigational oral antineoplastic agents. …”
Get full text
Article